Does ANI Pharmaceuticals' (ANIP) New Cardiovascular Generic Deepen Its Niche Strategy Or Stretch It?

In early April 2026, ANI Pharmaceuticals announced FDA approval and U.S. launch of its Isosorbide Mononitrate Tablet USP, 10 ...
Yahoo Finance

ANI Pharmaceuticals, Inc. Closes $316.25 Million Convertible Senior Notes Offering Including Full Exercise of Initial Purchasers’ Option to Purchase Additional Notes

PRINCETON, N.J., Aug. 13, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the closing of its offering of $316,250,000 aggregate principal amount ...
Twin Cities Business

ANI Pharmaceuticals Banks on Rare Disease Business

Amid the dozens of publicly traded firms in Minnesota, Baudette-based ANI Pharmaceuticals Inc. often flies under the radar. The pharmaceutical company about five hours north of Minneapolis has grown ...